Terms: = Brain cancer AND CLTCL1, CLTCL, 8218, ENSG00000070371, P53675 AND Treatment
3 results:
1. Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials.
Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB
Hematol Oncol; 2020 Aug; 38(3):229-243. PubMed ID: 31873944
[TBL] [Abstract] [Full Text] [Related]
2. Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma.
Huang B; Dolecek TA; Chen Q; Garcia CR; Pittman T; Villano JL
Med Oncol; 2018 Apr; 35(5):74. PubMed ID: 29667068
[TBL] [Abstract] [Full Text] [Related]
3. A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development.
Nahorski MS; Al-Gazali L; Hertecant J; Owen DJ; Borner GH; Chen YC; Benn CL; Carvalho OP; Shaikh SS; Phelan A; Robinson MS; Royle SJ; Woods CG
Brain; 2015 Aug; 138(Pt 8):2147-60. PubMed ID: 26068709
[TBL] [Abstract] [Full Text] [Related]
